Related Experiment Video
Updated: Jul 2, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Pyrrolocarbazoles as checkpoint 1 kinase inhibitors
Hélène Hénon1, Elisabeth Conchon, Bernadette Hugon
1Laboratoire SEESIB, Université Blaise Pascal, UMR 6504 du CNRS, 24 Avenue des Landais, 63177 Aubière, France. Michelle.PRUDHOMME@univ-bpclermont.fr
Abstract:
The carbazole framework is found in many natural compounds of biological interest. Indolocarbazoles such as rebeccamycin and staurosporine which are either a topoisomerase I inhibitor (rebeccamycin) or a non selective kinase inhibitor (staurosporine) are bacterial metabolites. In the search for new antitumor agents, DNA damage checkpoint kinases, in particular Checkpoint kinase 1, have recently emerged as attractive targets for cancer therapy. This review reports the synthesis and Chk1 inhibitory activities of pyrrolocarbazole compounds bearing four or five fused rings.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Negative Regulator Molecules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
